These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14739048)

  • 21. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
    Hinds A; Sheehan AG; Machida H; Parsons HG
    Diabetes Res; 1991 Oct; 18(2):69-78. PubMed ID: 1841815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
    J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.
    Oka R; Yagi K; Sakurai M; Nakamura K; Moriuchi T; Miyamoto S; Nohara A; Kawashiri MA; Takeda Y; Yamagishi M
    Endocr J; 2012; 59(1):55-64. PubMed ID: 22068110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of insulin resistance and beta-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis.
    Austin A; Kalhan SC; Orenstein D; Nixon P; Arslanian S
    J Clin Endocrinol Metab; 1994 Jul; 79(1):80-5. PubMed ID: 8027259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three methods for the quantification of beta-cell function and insulin sensitivity.
    Nijpels G; van der Wal PS; Bouter LM; Heine RJ
    Diabetes Res Clin Pract; 1994 Dec; 26(3):189-95. PubMed ID: 7736899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans.
    Gerst F; Jaghutriz BA; Staiger H; Schulte AM; Lorza-Gil E; Kaiser G; Panse M; Haug S; Heni M; Schütz M; Stadion M; Schürmann A; Marzetta F; Ibberson M; Sipos B; Fend F; Fleming T; Nawroth PP; Königsrainer A; Nadalin S; Wagner S; Peter A; Fritsche A; Richter D; Solimena M; Häring HU; Ullrich S; Wagner R
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4373-4383. PubMed ID: 30202879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
    Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function.
    Bonadonna RC; Stumvoll M; Fritsche A; Muggeo M; Häring H; Bonora E; van Haeften TW
    Diabetes; 2003 Feb; 52(2):470-80. PubMed ID: 12540623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin sensitivity and beta function in the first-degree relatives of type 2 diabetic patients].
    Han XY; Ji LN; Zhou XH
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1777-80. PubMed ID: 15631772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.
    Mari A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T
    PLoS One; 2013; 8(9):e73154. PubMed ID: 24019903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.
    Suzuki H; Fukushima M; Usami M; Ikeda M; Taniguchi A; Nakai Y; Matsuura T; Kuroe A; Yasuda K; Kurose T; Seino Y; Yamada Y
    Diabetes Care; 2003 Apr; 26(4):1211-5. PubMed ID: 12663599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.
    Miyazaki Y; Matsuda M; DeFronzo RA
    Diabetes Care; 2002 Mar; 25(3):517-23. PubMed ID: 11874940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.